Any stock, in context
EMCURE · Healthcare
Emcure Pharmaceuticals Ltd.
Observation · 15 Oct 2026
How these are readEmcure Pharmaceuticals closed at ₹1,836.0 on 15 Oct 2026, 8.0% above its 200-day average and 4.4% below its 50-day average: above the long line, below the short one. It sits 8.6% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 3.2%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +8.0%
- the long line
- vs 50-day
- −4.4%
- the short line
- From 52w high
- −8.6%
- ₹1,306.5₹2,100.7
- 3 months
- +3.2%
- sector median −2.7% · 53 of 146
Nifty Smallcap 250 · Healthcare · EQ series · median traded value ₹23 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −1.62%
- 1W
- –
- 1M
- −7.88%
- 3M
- +3.16%
- YTD
- –
- 1Y
- +34.82%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.